Icon (ICLR) Beginning Cash Balance (2009 - 2026)
Icon's (ICLR) quarterly Beginning Cash Balance came in at $647.3 million in Q2 2026, up 20.14% year-over-year from $538.8 million in Q2 2025, and little changed quarter-over-quarter from $647.3 million in Q1 2026.
Analysis
Icon (ICLR) Beginning Cash Balance (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Beginning Cash Balance for 18 consecutive years, with $647.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Beginning Cash Balance rose 20.14% year-over-year to $647.3 million in Q2 2026; TTM through Jun 2026 was $647.3 million, a 20.14% increase from a year earlier, with the FY2025 full-year figure at $538.8 million, up 42.5% from the prior year.
- Beginning Cash Balance was $647.3 million for Q2 2026 at Icon, roughly flat from $647.3 million in the prior quarter.
- Over five years, Beginning Cash Balance peaked at $840.3 million in Q4 2022 and troughed at $288.8 million in Q1 2023.
- A 5-year average of $511.9 million and a median of $538.8 million in 2025 frame the typical range for Beginning Cash Balance.
- Across the five-year window, Beginning Cash Balance plunged 65.64% in 2023 and soared 42.5% in 2025, its largest moves.
- Over 5 years, Beginning Cash Balance stood at $840.3 million in 2022, then sank by 65.64% to $288.8 million in 2023, then jumped by 30.94% to $378.1 million in 2024, then surged by 42.5% to $538.8 million in 2025, then rose by 20.14% to $647.3 million in 2026.
- The last three Beginning Cash Balance figures came in at $647.3 million (Q2 2026), $647.3 million (Q1 2026), and $538.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 647.30 Mn |
| Mar 31, 2026 | 647.30 Mn |
| Dec 31, 2025 | 538.79 Mn |
| Sep 30, 2025 | 538.79 Mn |
| Jun 30, 2025 | 538.79 Mn |
| Mar 31, 2025 | 538.79 Mn |
| Dec 31, 2024 | 378.10 Mn |
| Sep 30, 2024 | 378.10 Mn |
| Jun 30, 2024 | 378.10 Mn |
| Mar 31, 2024 | 378.10 Mn |
| Dec 31, 2023 | 288.77 Mn |
| Sep 30, 2023 | 288.77 Mn |
| Jun 30, 2023 | 288.77 Mn |
| Mar 31, 2023 | 288.77 Mn |
| Dec 31, 2022 | 840.31 Mn |
| Sep 30, 2022 | 752.21 Mn |
| Jun 30, 2022 | 752.21 Mn |
| Mar 31, 2022 | 752.21 Mn |
| Sep 30, 2021 | 840.31 Mn |
| Jun 30, 2021 | 840.31 Mn |